Clinical trials: Anti-Mullerian Hormone
Fertility Risk
Anti-Mullerian Hormone - At My Home
The AMH^2 (Anti-Mullerian Hormone - At My Home) study is a head-to-head-to-head validation study aiming to evaluate the concordance of AMH levels found in blood collected via three different routes: collected at-home using the…
- Trial name
- AMH^2 (NCT04784325)
- Testing
- Blood draw through TAP II, Blood draw through ADx cardT, Blood draw through standard venipuncture
- Where
- United States
- Volunteers
- 41 people, healthy volunteers welcome
- Sponsor
- Turtle Health, Inc.
Infertility
AMH and Pregnancy Rate by Age During Stimulate In-Vitro Fertilization Protocol
The woman fertility decrease with the age and there is a closely link with the ovarian reserve, the number of available eggs in the ovaries.
- Trial name
- NCT01762111
- Where
- Canada
- Sponsor
- Clinique Ovo
Anti-Mullerian Hormone
Clinical Performance Evaluation of AMH Assay
The Access AMH Assay is an in vitro diagnostic assay intended as an aid for fertility assessment. The purpose of the study is to evaluate the clinical performance of the Access AMH Assay in the intended use population.
- Trial name
- NCT03131388
- Testing
- Access AMH Assay
- Where
- 13 sites in United States, Canada
- Volunteers
- 277 people
- Sponsor
- Beckman Coulter, Inc.
Anti-Mullerian Hormone
Anti-Mullerian Hormone Levels Before and After an Open Myomectomy
Anti-Mullerian hormone (AMH) is a marker for ovarian reserve. It is well known that ovarian surgery for endometriosis lowers Anti-Mullerian hormone, but little is known for other surgeries.
- Trial name
- NCT01723085
- Where
- Canada
- Volunteers
- 21 people
- Sponsor
- Clinique Ovo